FFA
DYN icon

Farther Finance Advisors’s Dyne Therapeutics DYN Stock Holding History

Farther Finance Advisors’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444 Sell
20
-4
-17% -$74 ﹤0.01% 5559
2026
Q1 		$434 Buy
24
+7
+41% +$121 ﹤0.01% 5300
2025
Q4 		$333 Buy
17
+2
+13% +$38 ﹤0.01% 5113
2025
Q3 		$190 Buy
+15
New +$171 ﹤0.01% 4728
2025
Q1 		– Sell
-3
Closed -$71 – 4303
2024
Q4 		$71 Hold
3
– – ﹤0.01% 3837
2024
Q3 		$108 Buy
+3
New +$119 ﹤0.01% 3768

Other funds holding DYN

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's DYN Position: Q2 2026 in Review

Farther Finance Advisors reduced its Dyne Therapeutics (DYN) stake by 17% in Q2 2026, selling an estimated $74 and leaving 20 shares worth $444. The position accounts for ﹤0.01% of the portfolio, ranked #5559.

Farther Finance Advisors first reported a position in DYN in Q3 2024 and has held it in 6 quarters since. 12 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Farther Finance Advisors held 20 shares of Dyne Therapeutics worth $444 as of Q2 2026.
  • Farther Finance Advisors sold 4 Dyne Therapeutics shares in Q2 2026, an estimated $74.
  • Dyne Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5559 holding.
  • Farther Finance Advisors first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 12 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.